Biotech company Beleave Inc. (
CSE: C.BE,
BLEVF,
Forum) announced Friday that Health Canada will conduct a pre-sale inspection of their operation to confirm that the company’s production, testing, manufacturing, packaging, storing, labelling, shipping and record-keeping of product intended for sale is in compliance with the requirements of the
Access to Cannabis for Medical Purposes Regulations (
ACMPR). Health Canada could issue a sales license after a satisfactory pre-sale inspection.
More information can be found
here.
Health Canada recently granted Beleave Inc. a licence to begin
commercial production of cannabis oils.
The company was also in the news recently for
signing a Brand Licensing Agreement with filmmaker and actor Kevin Smith.
Beleave Inc.’s wholly-owned subsidiary,
Beleave Kannabis Corp., is a licensed producer under the ACMPR with a purpose-built facility in Hamilton, Ontario.
FULL DISCLOSURE: Believe Inc. is a paid client of Stockhouse Publishing.